[Position paper of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC) on driving by patients with cardiac implantable electronic devices].

Position paper dell’Associazione Italiana di Aritmologia e Cardiostimolazione (AIAC): Raccomandazioni sull’idoneità alla guida dei pazienti portatori di dispositivi cardiaci impiantabili.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Oct 2020
Historique:
entrez: 24 9 2020
pubmed: 25 9 2020
medline: 16 7 2021
Statut: ppublish

Résumé

In patients with cardiac implantable electronic devices (CIEDs) (implantable cardioverter-defibrillators [ICDs] and pacemakers [PMs]), the potential risk of suddenly being unable to drive, and hence of causing road accidents, is higher than in the general population. In ICD patients, this risk stems from the possibility that an arrhythmic event leading to loss of consciousness may occur while driving. In PM patients, it may be the result of a device malfunction in a PM-dependent patient. To determine a CIED patient's ability to drive, two variables must be taken into account: (i) the risk of events, which depends on the type of underlying heart disease (ICD patients have a higher risk than PM patients); (ii) the time spent driving and the type of vehicle driven (professional drivers are at higher risk than private drivers). This position paper reports the recommendations of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC) regarding driving by patients with CIEDs, on the basis of the available literature and the European reference recommendations.

Identifiants

pubmed: 32968320
doi: 10.1714/3431.34209
doi:

Types de publication

Journal Article Practice Guideline

Langues

ita

Sous-ensembles de citation

IM

Pagination

819-825

Auteurs

Pietro Palmisano (P)

A.O. "Cardinal G. Panico", Tricase (LE).

Federico Guerra (F)

Università Politenica delle Marche, Ospedali Riuniti, Ancona.

Giovanni Bisignani (G)

Ospedale di Castrovillari, Castrovillari (CS).

Giovanni Battista Forleo (GB)

Ospedale Luigi Sacco, Milano.

Maurizio Landolina (M)

A.O. Ospedale Maggiore di Crema, Crema (CR).

Ezio Soldati (E)

Ospedale Cisanello, Pisa.

Giuseppe Stabile (G)

Clinica Montevergine, Mercogliano (AV), Clinica San Michele, Maddaloni (CE).

Gabriele Zanotto (G)

Ospedale Mater Salutis, Legnago (VR).

Massimo Zoni Berisso (MZ)

ASL 3 Padre Picone, Genova.

Roberto De Ponti (R)

Ospedale di Circolo, Università dell'Insubria, Varese.

Giuseppe Boriani (G)

Università di Modena e Reggio Emilia, Policlinico di Modena, Modena.

Renato Pietro Ricci (RP)

Centro CardioAritmologico, Roma.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH